World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   5645 records for 1349 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2013-004679-11-HU
A clinical trial for patients with breast cancer
17/06/2014
Not recruitingNCT02163759
A Study of the Efficacy and Safety of Etrolizumab Treatment, Compared With Adalimumab and Placebo, in Inducing Disease Remission in Ulcerative Colitis Patients Who Have Not Previously Received TNF Inhibitors
12/06/2014
Not recruitingNCT02127697
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
29/04/2014
AuthorisedEUCTR2013-003431-29-IT
A medical follow-up study in patients who received BGG492 for more than 28 days.
Recruitment statusMain IDPublic titleDate of registration
Not recruitingNCT02150213Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG49215/05/2014
28/04/2014
Not recruitingNCT02119494
Phenotypes of COPD in Central and Eastern Europe
16/04/2014
RecruitingISRCTN25644448
EXCOA-CVT study: the benefit of EXtending oral antiCOAgulation treatment after acute Cerebral Vein Thrombosis
10/04/2014
AuthorisedEUCTR2013-005550-30-SK
Study to assess the clinical efficacy and safety of SUBLIVAC FIX Birch immunotherapy in patients with allergic rhinitis/rhinoconjunctivitis caused by birch pollen
07/04/2014
RecruitingNCT02105961
Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)
03/04/2014
AuthorisedEUCTR2013-005020-42-SK
Randomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Recruitment statusMain IDPublic titleDate of registration
RecruitingNCT02106546Randomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer04/04/2014
AuthorisedEUCTR2013-005020-42-FIRandomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)26/03/2014
AuthorisedEUCTR2013-005020-42-NORandomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)02/06/2014
AuthorisedEUCTR2013-005020-42-LTRandomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)02/04/2014
AuthorisedEUCTR2013-005020-42-DERandomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)04/06/2014
AuthorisedEUCTR2013-005020-42-ATRandomized, Double-Blind, Multicenter, Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)04/06/2014
24/03/2014
AuthorisedEUCTR2013-004297-98-SK
English Study evaluating safety and efficacy of mepolizumab in the treatment of COPD patients with frequent exacerbations. 21/03/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history